Townsend Adam J. 4
4 · Apellis Pharmaceuticals, Inc. · Filed Jan 14, 2025
Insider Transaction Report
Form 4
Townsend Adam J.
Chief Commercial Officer
Transactions
- Sale
Common Stock
2025-01-13$28.70/sh−2,685$77,065→ 90,269 total
Footnotes (2)
- [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 10, 2025.
- [F2]This includes 501 shares from April 30, 2024 ESPP purchase.